Xyosted 75 MG/0.5 ML auto-INJ 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM7A8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,311
Award facts
- Contract value 100% obligated
- $1,311.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,311.45 to AmerisourceBergen Drug Corp for Xyosted 75 mg/0.5 mL auto-injector supplies. The contract is non-competitive with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of December 17, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026.
AmerisourceBergen serves as a critical pharmaceutical distributor for federal medical procurement, supplying medications and medical devices to Defense Health Agency, military healthcare systems, and other government entities. The company's extensive portfolio with DLA includes specialty medications, generic and brand-name drugs, vaccines, and medical supplies across multiple therapeutic categories. Xyosted is a testosterone replacement therapy product delivered via auto-injector, commonly used in military and veteran healthcare systems. AmerisourceBergen's DLA contracts demonstrate the company's capability to fulfill federal medical supply requirements through competitive procurement processes and comprehensive delivery mechanisms supporting military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FM7A8?
SPE2DR26FM7A8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26FM7A8 worth?
The government has obligated $1,311 on SPE2DR26FM7A8.
Is contract SPE2DR26FM7A8 an order under another contract?
Yes. SPE2DR26FM7A8 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM7A8 competed?
The extent of competition for SPE2DR26FM7A8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award